Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group Study

被引:274
|
作者
Mulhern, RK
Kepner, JL
Thomas, PR
Armstrong, FD
Friedman, HS
Kun, LE
机构
[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[2] Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN USA
[3] Univ Tennessee, Coll Med, Dept Radiat Oncol, Memphis, TN USA
[4] Univ Florida, Dept Stat, Pediat Oncol Grp, Stat Off, Gainesville, FL 32611 USA
[5] Univ Miami, Sch Med, Dept Pediat, Miami, FL USA
[6] Temple Univ, Ctr Canc, Philadelphia, PA 19122 USA
[7] Temple Univ, Dept Radiat Oncol, Philadelphia, PA 19122 USA
[8] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
关键词
D O I
10.1200/JCO.1998.16.5.1723
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of this study was to ten the hypothesis that survivors of medulloblastoma who were younger at diagnosis and those who received standard-dose cranial irradiation (SRT) of 36 Gy would have a lower performance on standardized tests of cognitive function and achievement than children who were older and those treated with reduced-dose cranial irradiation (RRT) of 23.4 Gy. Patients and Methods: Eligible patients had been treated on Pediatric Oncology Group (POG) study 8631 for law-risk medulloblastoma that randomized patients to receive RRT or SRT after surgical resection. Those who were alive and free of progressive disease 6.1 to 9.9 years from completion of treatment were eligible for this study. Of the 35 eligible patients, 22 patients (13 SRT, nine RRT) participated in a battery of tests that included intellectual and academic development as well as ratings of health-related quality of life. Results: Patients were stratified by treatment group (SRT v RRT) and into younger (Y) and older (O) groups by the median age at diagnosis (8.85 years), which resulted in four groups that we hypothesized would show neuropsychologic test scores in the following order: Y/SRT less than Y/RRT less than O/SRT less than O/RRT. Evidence to support the hypothesized ordering of groups in terms of neuropsychologic toxicity wets obtained with regard to Performance Intelligence Quotient (IQ), Full Scale IQ, Attention, Reading, and Arithmetic. Conclusion: Children heated for medulloblastoma experienced less severe neuropsychologic toxicity when heated with 23.4 Gy instead of 36 Gy cranial irradiation. Older children experienced less toxicity than children who were younger at the time of irradiation. (C) 1998 by American Society of Clinical Oncology.
引用
收藏
页码:1723 / 1728
页数:6
相关论文
共 50 条
  • [31] Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: A 5-year follow-up study
    Wahba, H. A.
    Abu-Hegazy, M.
    Wasel, Y.
    Ismail, E. I.
    Zidan, A. S.
    JOURNAL OF BUON, 2013, 18 (02): : 425 - 429
  • [32] Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study
    Wahba, H. A.
    Abu-Hegazy, M.
    Wasel, Y.
    Ismail, E. I.
    Zidan, A. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 67 - 67
  • [33] TOXICITY OF HIGH-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ADVANCED CHILDHOOD TUMORS RESISTANT TO CONVENTIONAL THERAPY - A PEDIATRIC ONCOLOGY GROUP-STUDY
    TEBBI, CK
    KRISCHER, J
    FERNBACH, DJ
    MAHONEY, DH
    ALVARADO, C
    CAMITTA, B
    CANCER, 1990, 66 (10) : 2064 - 2067
  • [34] Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600cGy/2O) with reduced neuraxis irradiation (2,340cGy/13) in patients with low-stage medulloblastoma - A combined Children's Cancer Group Pediatric Oncology Group Study
    Deutsch, M
    Thomas, PRM
    Krischer, J
    Boyett, JM
    Albright, L
    Aronin, P
    Langston, J
    Allen, JC
    Packer, RJ
    Linggood, R
    Mulhern, R
    Stanley, P
    Stehbens, JA
    Duffner, P
    Kun, L
    Rorke, L
    Cherlow, J
    Freidman, H
    Finlay, JL
    Vietti, T
    PEDIATRIC NEUROSURGERY, 1996, 24 (04) : 167 - 176
  • [35] OUTCOMES OF CHILDREN WITH STANDARDRISK AND HIGH-RISK MEDULLOBLASTOMA TREATED WITH PRE-IRRADIATION CHEMOTHERAPY AND RISK-ADAPTED CRANIOSPINAL IRRADIATION: A REPORT ON PATIENTS FROM THE POLISH PEDIATRIC NEURO-ONCOLOGY GROUP
    Perek-Polnik, Marta
    Cochrane, Anne
    Chojnacka, M.
    Drogosiewicz, M.
    Filipek, I.
    Swieszkowska, E.
    Tarasinska, M.
    Kowalczyk, P.
    Abdelbaki, Mohamed S.
    Dembowska-Baginska, Bozenna
    NEURO-ONCOLOGY, 2022, 24 : 110 - 110
  • [37] cGy of craniospinal radiotherapy (CSRT) plus chemotherapy for children with "average-risk" medulloblastoma (MB): A prospective randomized children's oncology group study (A9961)
    Packer, RJ
    Gajjar, A
    Vezina, G
    Langston, J
    Rorke, L
    Burger, P
    Robertson, P
    Murasko, K
    Armstrong, D
    Ris, D
    LaFond, D
    Boyer, L
    Sposto, R
    NEURO-ONCOLOGY, 2004, 6 (04) : 387 - 387
  • [38] High-Dose Methotrexate-Induced Hepatotoxicity in Childhood Osteosarcoma: A Study from the Taiwan Pediatric Oncology Group
    Hou, M. H.
    Lin, M. T.
    Jou, S. T.
    Yang, C. P.
    Hsieh, Y. L.
    Chang, T. K.
    Hung, I. J.
    Lin, D. T.
    Chen, B. W.
    Hung, G. Y.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S253 - S253
  • [39] Local Control With Reduced-Dose Radiotherapy for Low-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group D9602 Study
    Breneman, John
    Meza, Jane
    Donaldson, Sarah S.
    Raney, R. Beverly
    Wolden, Suzanne
    Michalski, Jeff
    Laurie, Fran
    Rodeberg, David A.
    Meyer, William
    Walterhouse, David
    Hawkins, Douglas S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (02): : 720 - 726
  • [40] Atypical teratoid/rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma - A pediatric oncology group study
    Burger, PC
    Yu, IT
    Tihan, T
    Friedman, HS
    Strother, DR
    Kepner, JL
    Duffner, PK
    Kun, LE
    Perlman, EJ
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (09) : 1083 - 1092